Principles of Administration of Cardiac Medications
| Class IA: |
|
| Class IB: |
|
| Class II: (β-Blockers) |
|
| Class III: |
|
| Class IV: (Ca++ Channel Blockers) |
|
| Other Antidysrhythmic Drugs: |
|
| Sympathomimetic Agents: |
|
| Vasodilators: |
|
| ACE Inhibitors: |
|
| Angiotensin II Receptor Blockers: |
|
| Diuretics: |
|
| Calcium Channel Blockers: |
|
| Phosphodiesterase Inhibitors: |
|
| Cardiac Glycoside |
|
Anticoagulant/Antiplatelet/Fibrinolytic Medications
| Anticoagulants: |
|
| Antiplatelets: |
|
| Glycoprotein IIb/IIIa Inhibitors: |
|
| Fibrinolytic Agents: |
|
| Recombinent Human Activated Protein C |
[FDA withdrawn] |
Other Cardiac Medications
| HMG-VoA Reductase Inhibitors ("statins") |
|
| Antidotes: |
|